0.65
Metavia Inc stock is traded at $0.65, with a volume of 84,179.
It is up +1.72% in the last 24 hours and down -7.14% over the past month.
MetaVia Inc is a clinical-stage biotechnology company focused on developing novel pharmaceuticals to treat cardiometabolic diseases. It has two programs focused on the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and obesity. DA-1241 is a novel G-Protein-Coupled Receptor 119 (GPR119) agonist with development optionality as a standalone and/or combination therapy for both MASH and Type 2 Diabetes Mellitus (T2DM). DA-1726 is a novel oxyntomodulin (OXM) analogue functioning as a GLP-1 receptor (GLP1R) and glucagon receptor (GCGR) dual agonist for the treatment of obesity that is designed to be administered once weekly subcutaneously.
See More
Previous Close:
$0.639
Open:
$0.64
24h Volume:
84,179
Relative Volume:
0.33
Market Cap:
$15.73M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+1.56%
1M Performance:
-7.14%
6M Performance:
-59.47%
1Y Performance:
+0.00%
Metavia Inc Stock (MTVA) Company Profile
Name
Metavia Inc
Sector
Industry
Phone
(857) 702-9600
Address
545 CONCORD AVENUE, CAMBRIDGE
Compare MTVA with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
MTVA
Metavia Inc
|
0.65 | 15.74M | 0 | 0 | 0 | 0.00 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Metavia Inc Stock (MTVA) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Dec-30-24 | Initiated | H.C. Wainwright | Buy |
Metavia Inc Stock (MTVA) Latest News
Candlestick Signal Suggests Reversal in MetaVia Inc.July 2025 Earnings & Weekly Stock Performance Updates - thegnnews.com
Is it time to cut losses on MetaVia Inc.2025 Market Sentiment & Daily Profit Focused Screening - Newser
Visual analytics tools that track MetaVia Inc. performance2025 Pullback Review & Weekly Market Pulse Alerts - Newser
Using data models to predict MetaVia Inc. stock movementJuly 2025 Summary & Free Safe Entry Trade Signal Reports - Newser
Chart overlay techniques for tracking MetaVia Inc.Portfolio Performance Summary & Real-Time Volume Spike Alerts - Newser
MetaVia Inc. stock daily chart insightsMarket Risk Report & Reliable Price Breakout Signals - Newser
Is MetaVia Inc. stock poised for growthWeekly Trade Report & AI Forecasted Entry and Exit Points - Newser
How to interpret RSI for MetaVia Inc. stockEarnings Performance Report & Accurate Buy Signal Notifications - Newser
Market reaction to MetaVia Inc.’s recent newsWeekly Risk Report & High Conviction Trade Alerts - Newser
MetaVia Inc. stock chart pattern explained2025 Dividend Review & Community Driven Trade Alerts - Newser
Can you recover from losses in MetaVia Inc.July 2025 Reactions & Community Supported Trade Ideas - Newser
Can MetaVia Inc. hit a new high this monthJuly 2025 Retail & Real-Time Chart Pattern Alerts - Newser
Momentum divergence signals in MetaVia Inc. chartTrade Signal Summary & Entry Point Strategy Guides - Newser
Multi asset correlation models including MetaVia Inc.Market Weekly Review & Intraday High Probability Setup Alerts - Newser
Will MetaVia Inc. outperform the market2025 Retail Activity & Long-Term Safe Investment Plans - Newser
MetaVia Inc. Building a Base Near SupportEarnings Overview Summary & Free Safe Entry Trade Signal Reports - mustnews.co.kr
MetaVia Inc. stock volume spike explained2025 Volatility Report & AI Powered Market Trend Analysis - Newser
Applying big data sentiment scoring on MetaVia Inc.Portfolio Update Summary & Short-Term Trading Alerts - Newser
Analyzing recovery setups for MetaVia Inc. investors2025 Top Decliners & Intraday High Probability Alerts - Newser
What institutional flow reveals about MetaVia Inc.Trade Volume Report & Technical Entry and Exit Tips - Newser
Using Python tools to backtest MetaVia Inc. strategiesGlobal Markets & Stepwise Trade Execution Plans - Newser
Metavia Inc Stock (MTVA) Financials Data
There is no financial data for Metavia Inc (MTVA). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
Metavia Inc Stock (MTVA) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
DONG-A ST CO., LTD | 10% Owner |
May 08 '25 |
Buy |
0.71 |
4,647,887 |
3,300,000 |
9,995,679 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):